MORGAN STANLEY PLC/PUT/MERCK & CO./100/0.1/20.06.25 Share Price

Warrant

DE000MB71SB9

Market Closed - Börse Stuttgart 19:16:18 28/06/2024 BST
0.221 EUR -6.36% Intraday chart for MORGAN STANLEY PLC/PUT/MERCK & CO./100/0.1/20.06.25
Current month-15.00%
1 month+10.50%
Date Price Change
28/06/24 0.221 -6.36%
27/06/24 0.236 +15.69%
26/06/24 0.204 +6.25%
25/06/24 0.192 0.00%
24/06/24 0.192 -10.70%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 07:16 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MB71SB
ISINDE000MB71SB9
Date issued 06/06/2023
Strike 100 $
Maturity 20/06/2025 (356 Days)
Parity 10 : 1
Emission price 0.89
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.02
Lowest since issue 0.18
Spread 0.004
Spread %1.61%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
123.8 USD
Average target price
142.7 USD
Spread / Average Target
+15.25%
Consensus